The elevated levels of IL-1β and IL-18 observed in COVID-19 patients with CRS support the involvement of the DDR and DNA sensing, via downstream inflammasome activation, amplifying inflammation and contributing to tissue injury. Here, IL1B is linked to COVID-19.